BioScience Managers Capital Return on Healthcare Fund I Locks in 24.7% IRR for Investors
Outstanding capital return in final distribution for Australian Bioscience Fund I Australia’s best performing biotech fund in recent years as per Cambridge Associates ratings 13 August 2014: AusBiotech Industry Spotlight here. Leading Australian healthcare fund manager Bioscience Managers has maintained its exceptional performance by returning capital to investors from its Australian Bioscience Fund I at 24.7% […]